glp 1 news Glp-1 news. This is truly gossip girl. , Thanks to @drnadolsky for being my fact checker :) , #medicine #weightloss #news #doctor #health GLP-1 receptor agonists show promise

Across trials, 30% to 80% of patients achieve hemoglobin A1c targets below 7%, with semaglutide often producing the greatest reductions

For weight management, the Food and Drug Administration (FDA) has approved two medications: Semaglutide (Wegovy) Tirzepatide (Zepbound) These drugs contain the same active ingredients as diabetes medications such as Ozempic and Mounjaro, but Wegovy and Zepbound are specifically approved for chronic weight management

She is now taking a GLP1RA that has made transformative difference in her weight (she lost 20 pounds over two months) and metabolic control

People who combine these medications with good nutrition and regular exercise see the best results

We were MANAGING her disease, Rothberg says

As shortages of brand-name GLP-1 medications begin to ease, regulators are increasing scrutiny on these platforms to ensure patient safety and compliance, signaling a broader crackdown on unapproved or gray-market weight-loss treatments